143 related articles for article (PubMed ID: 22655246)
1. FDG Dose Extravasations in PET/CT: Frequency and Impact on SUV Measurements.
Osman MM; Muzaffar R; Altinyay ME; Teymouri C
Front Oncol; 2011; 1():41. PubMed ID: 22655246
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Appearance of aseptic vascular grafts after endovascular aortic repair on [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography.
Bennett P; Tomas MB; Koch CF; Nichols KJ; Palestro CJ
World J Radiol; 2023 Aug; 15(8):241-249. PubMed ID: 37662425
[TBL] [Abstract][Full Text] [Related]
4. Simulated Reduced-Count Whole-Body FDG PET: Evaluation in Children and Young Adults Imaged on a Digital PET Scanner.
Alves VPV; Brady S; Ata NA; Li Y; MacLean J; Zhang B; Sharp SE; Trout AT
AJR Am J Roentgenol; 2022 Dec; 219(6):952-961. PubMed ID: 35731102
[No Abstract] [Full Text] [Related]
5. Correction for FDG PET dose extravasations: Monte Carlo validation and quantitative evaluation of patient studies.
Silva-Rodríguez J; Aguiar P; Sánchez M; Mosquera J; Luna-Vega V; Cortés J; Garrido M; Pombar M; Ruibal A
Med Phys; 2014 May; 41(5):052502. PubMed ID: 24784399
[TBL] [Abstract][Full Text] [Related]
6. Ferret thoracic anatomy by 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) imaging.
Wu A; Zheng H; Kraenzle J; Biller A; Vanover CD; Proctor M; Sherwood L; Steffen M; Ng C; Mollura DJ; Jonsson CB
ILAR J; 2012; 53(1):E9-21. PubMed ID: 23382267
[TBL] [Abstract][Full Text] [Related]
7. Significance of SUV on Follow-up F-18 FDG PET at the Anastomotic Site of Gastroduodenostomy after Distal Subtotal Gastrectomy in Patients with Gastric Cancer.
Choi BW; Zeon SK; Kim SH; Jo I; Kim HW; Won KS
Nucl Med Mol Imaging; 2011 Dec; 45(4):285-90. PubMed ID: 24900019
[TBL] [Abstract][Full Text] [Related]
8. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma.
Hoffmann M; Vogelsang H; Kletter K; Zettinig G; Chott A; Raderer M
Gut; 2003 Mar; 52(3):347-51. PubMed ID: 12584214
[TBL] [Abstract][Full Text] [Related]
9. Value of true whole-body FDG-PET/CT scanning protocol in oncology: optimization of its use based on primary diagnosis.
Sebro R; Mari-Aparici C; Hernandez-Pampaloni M
Acta Radiol; 2013 Jun; 54(5):534-9. PubMed ID: 23463863
[TBL] [Abstract][Full Text] [Related]
10. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
[TBL] [Abstract][Full Text] [Related]
11. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE
Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic accuracy of
Lemans JVC; Hobbelink MGG; IJpma FFA; Plate JDJ; van den Kieboom J; Bosch P; Leenen LPH; Kruyt MC; Glaudemans AWJM; Govaert GAM
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):999-1008. PubMed ID: 30523391
[TBL] [Abstract][Full Text] [Related]
13. Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size.
Kurland BF; Muzi M; Peterson LM; Doot RK; Wangerin KA; Mankoff DA; Linden HM; Kinahan PE
J Nucl Med; 2016 Feb; 57(2):226-30. PubMed ID: 26493206
[TBL] [Abstract][Full Text] [Related]
14. [The Application Value of True Whole-body PET/CT Scanning Protocol in Patients of Extranodal NK/T Cell Lymphoma].
Li FL; Su MG; Shi DZ; Liang FL; Li L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 51(2):245-251. PubMed ID: 32220195
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG PET/CT of patients with cancer: comparison of whole-body and limited whole-body technique.
Osman MM; Chaar BT; Muzaffar R; Oliver D; Reimers HJ; Walz B; Nguyen NC
AJR Am J Roentgenol; 2010 Dec; 195(6):1397-403. PubMed ID: 21098201
[TBL] [Abstract][Full Text] [Related]
16. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
Delbeke D; Rose DM; Chapman WC; Pinson CW; Wright JK; Beauchamp RD; Shyr Y; Leach SD
J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771
[TBL] [Abstract][Full Text] [Related]
17. Application of the long axial field-of-view PET/CT with low-dose [
Sachpekidis C; Pan L; Kopp-Schneider A; Weru V; Hassel JC; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1158-1167. PubMed ID: 36474125
[TBL] [Abstract][Full Text] [Related]
18. Is True Whole-Body
Cerci JJ; Etchebehere EC; Nadel H; Brink A; Bal CS; Rangarajan V; Pfluger T; Kagna O; Alonso O; Begum FK; Mir KB; Magboo VP; Menezes LJ; Paez D; Pascual TN
J Nucl Med; 2019 Aug; 60(8):1087-1093. PubMed ID: 30683766
[TBL] [Abstract][Full Text] [Related]
19. 18F-FLUORODEOXYGLUCOSE PET/CT CAN BE AN ALTERNATIVE METHOD TO ASSESSMENT OF INSULIN RESISTANCE.
Altun Tuzcu S; Cetin FA; Pekkolay Z; Tuzcu AK
Acta Endocrinol (Buchar); 2019; 15(4):539-543. PubMed ID: 32377256
[TBL] [Abstract][Full Text] [Related]
20. Test-Retest Reproducibility of
Kurland BF; Peterson LM; Shields AT; Lee JH; Byrd DW; Novakova-Jiresova A; Muzi M; Specht JM; Mankoff DA; Linden HM; Kinahan PE
J Nucl Med; 2019 May; 60(5):608-614. PubMed ID: 30361381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]